BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Prognosis
39 results:

  • 1. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 2. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal cancer Patients: An Exploratory Study.
    Cayún JP; Cerpa LC; Colombo A; Cáceres DD; Leal JL; Reyes F; Gutiérrez-Cáceres C; Calfunao S; Varela NM; Quiñones LA
    Curr Oncol; 2024 Jan; 31(1):274-295. PubMed ID: 38248103
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ZBTB7B is a permissive regulator of hepatocellular carcinoma initiation by repressing c-Jun expression and function.
    Zhu Y; Wang Q; Xie X; Ma C; Qiao Y; Zhang Y; Wu Y; Gao Y; Jiang J; Liu X; Chen J; Li C; Ge G
    Cell Death Dis; 2024 Jan; 15(1):55. PubMed ID: 38225233
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal cancer after Treatment Termination.
    Simmons K; Thomas JV; Ludford K; Willis JA; Higbie VS; Raghav KPS; Johnson B; Dasari A; Kee BK; Parseghian CM; Lee MS; Le PH; Morelli MP; Shen JP; Bent A; Vilar E; Wolff RA; Kopetz S; Overman MJ; Morris VK
    Cancer Res Commun; 2023 Dec; 3(12):2510-2517. PubMed ID: 38085001
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
    BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
    Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
    Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma.
    Rimini M; Macarulla T; Burgio V; Lonardi S; Niger M; Scartozzi M; Rapposelli IG; Aprile G; Ratti F; Pedica F; Verdaguer H; Nappo F; Nichetti F; Lai E; Valgiusti M; Cappetta A; Febregat C; Fassan M; De Braud F; Puzzoni M; Frassineti GL; Simionato F; De Cobelli F; Aldrighetti L; Fornaro L; Cascinu S; Casadei-Gardini A
    Eur J Cancer; 2022 Aug; 171():232-241. PubMed ID: 35749808
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
    Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
    Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic value of the combination of primary tumor location and RAS mutational status on patients with colorectal liver metastasis undergoing hepatectomy.
    Yan XL; Wang K; Bao Q; Wang HW; Jin KM; Su YM; Xing BC
    J Surg Oncol; 2022 May; 125(6):1002-1012. PubMed ID: 35171534
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
    Qin P; Zhang M; Liu X; Dong Z
    J Healthc Eng; 2021; 2021():3761858. PubMed ID: 34745496
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/nras/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.
    Xu X; Huang F; Cao M; Chen X; Wang H; Jiang H; Yu Y; Shen M; Yang Y; Wang B; Liu T; Guo W
    J Clin Lab Anal; 2021 Sep; 35(9):e23818. PubMed ID: 34403504
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
    Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. EPHB2 Activates β-Catenin to Enhance cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
    Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting nras by sponging miR-22-3p.
    Song W; Zheng C; Liu M; Xu Y; Qian Y; Zhang Z; Su H; Li X; Wu H; Gong P; Li Y; Fan H
    Mol Ther; 2021 Aug; 29(8):2601-2616. PubMed ID: 33839325
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Conversion therapy in patients with colorectal liver metastases.
    Villard C; Habib M; Nordenvall C; Nilsson PJ; Jorns C; Sparrelid E
    Eur J Surg Oncol; 2021 Aug; 47(8):2038-2045. PubMed ID: 33640172
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer.
    Petriv N; Neubert L; Vatashchuk M; Timrott K; Suo H; Hochnadel I; Huber R; Petzold C; Hrushchenko A; Yatsenko AS; Shcherbata HR; Wedemeyer H; Lichtinghagen R; Falfushynska H; Lushchak V; Manns MP; Bantel H; Semchyshyn H; Yevsa T
    Oncoimmunology; 2021 Feb; 10(1):1874159. PubMed ID: 33628620
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification and analysis of circRNA-miRNA-mRNA regulatory network in hepatocellular carcinoma.
    Zhou D; Dong L; Yang L; Ma Q; Liu F; Li Y; Xiong S
    IET Syst Biol; 2020 Dec; 14(6):391-398. PubMed ID: 33399102
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genomic and prognostic heterogeneity among RAS/BRAF
    Berg KCG; Brunsell TH; Sveen A; Alagaratnam S; Bjørnslett M; Hektoen M; Brudvik KW; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA
    Mol Oncol; 2021 Apr; 15(4):830-845. PubMed ID: 33325154
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review.
    Sanlorenzo M; Ribero S; Osella Abate S; Mariani S; Strignano P; Salizzoni M; Savoia P; Fierro MT; Quaglino P
    G Ital Dermatol Venereol; 2020 Oct; 155(5):680-682. PubMed ID: 33295742
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.